OncoCyte Price to Free Cash Flow Ratio 2014-2024 | OCX
Historical price to free cash flow ratio values for OncoCyte (OCX) since 2014.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| OncoCyte Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-12 | 2.81 | 0.00 | |
| 2024-12-31 | 2.38 | $-1.62 | 0.00 |
| 2024-09-30 | 2.85 | $-1.93 | 0.00 |
| 2024-06-30 | 2.95 | $-1.96 | 0.00 |
| 2024-03-31 | 2.93 | $-2.11 | 0.00 |
| 2023-12-31 | 2.50 | $-3.04 | 0.00 |
| 2023-09-30 | 3.12 | $-4.60 | 0.00 |
| 2023-06-30 | 4.60 | $-6.05 | 0.00 |
| 2023-03-31 | 7.09 | $-7.18 | 0.00 |
| 2022-12-31 | 6.42 | $-9.01 | 0.00 |
| 2022-09-30 | 14.60 | $-8.52 | 0.00 |
| 2022-06-30 | 17.99 | $-9.09 | 0.00 |
| 2022-03-31 | 29.80 | $-9.21 | 0.00 |
| 2021-12-31 | 43.40 | $-8.59 | 0.00 |
| 2021-09-30 | 71.20 | $-8.81 | 0.00 |
| 2021-06-30 | 114.80 | $-8.26 | 0.00 |
| 2021-03-31 | 103.80 | $-8.66 | 0.00 |
| 2020-12-31 | 47.80 | $-8.31 | 0.00 |
| 2020-09-30 | 27.80 | $-8.71 | 0.00 |
| 2020-06-30 | 38.20 | $-8.72 | 0.00 |
| 2020-03-31 | 49.00 | $-7.41 | 0.00 |
| 2019-12-31 | 45.00 | $-8.04 | 0.00 |
| 2019-09-30 | 42.00 | $-7.14 | 0.00 |
| 2019-06-30 | 49.80 | $-6.38 | 0.00 |
| 2019-03-31 | 79.00 | $-7.31 | 0.00 |
| 2018-12-31 | 27.60 | $-6.17 | 0.00 |
| 2018-09-30 | 50.00 | $-6.97 | 0.00 |
| 2018-06-30 | 51.00 | $-7.90 | 0.00 |
| 2018-03-31 | 42.00 | $-8.38 | 0.00 |
| 2017-12-31 | 93.00 | $-8.93 | 0.00 |
| 2017-09-30 | 151.00 | $-8.51 | 0.00 |
| 2017-06-30 | 104.00 | $-7.12 | 0.00 |
| 2017-03-31 | 119.00 | $-6.32 | 0.00 |
| 2016-12-31 | 141.00 | $-5.75 | 0.00 |
| 2016-09-30 | 100.80 | $-7.63 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.082B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |